Literature DB >> 3492379

Suppression of overt diabetes in NOD mice by anti-thymocyte serum or anti-Thy 1, 2 antibody.

M Harada, S Makino.   

Abstract

Effects of anti-thymocyte serum (ATS) and anti-Thy 1, 2 monoclonal antibody on the spontaneously occurring diabetes in NOD mice were examined. Spontaneous diabetes in female mice was markedly suppressed by intravenous injection of rabbit anti-mouse thymocyte serum diluted to 1:4 on three consecutive days during the time period from 70 to 100 days after birth; the cumulative incidence of overt diabetes upto 195 days of age was greatly reduced and the onset of diabetes was delayed. Similar effect was observed with anti-Thy 1, 2 antibody treatment. These findings suggest that T lymphocytes play a role in the production of spontaneous diabetes in this mouse strain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492379     DOI: 10.1538/expanim1978.35.4_501

Source DB:  PubMed          Journal:  Jikken Dobutsu        ISSN: 0007-5124


  17 in total

1.  An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice.

Authors:  K Kino; K Mizumoto; T Sone; T Yamaji; J Watanabe; A Yamashita; K Yamaoka; K Shimizu; K Ko; H Tsunoo
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

2.  Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.

Authors:  D V Serreze; E H Leiter; L D Shultz
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

3.  Suppression of concanavalin A-induced responses in splenic lymphocytes by activated macrophages in the non-obese diabetic mouse.

Authors:  K Yokono; Y Kawase; M Nagata; N Hatamori; S Baba
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

4.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 5.  Temporal discontinuities in progression of NOD autoimmune diabetes.

Authors:  G B Rudy; R M Sutherland; A M Lew
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

6.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

7.  The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.

Authors:  A Kasuga; T Maruyama; I Takei; A Shimada; T Kasatani; K Watanabe; T Saruta; T Nakaki; S Habu; J Miyazaki
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

8.  Effect of T-cell receptor V beta-specific monoclonal antibodies on cyclophosphamide-induced diabetes mellitus in non-obese diabetic mice.

Authors:  T Taki; K Yokono; K Amano; N Hatamori; Y Hirao; Y Tominaga; S Maeda; M Kasuga
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

9.  Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.

Authors:  C Mathieu; M Waer; J Laureys; O Rutgeerts; R Bouillon
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

10.  In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice.

Authors:  D Healey; P Ozegbe; S Arden; P Chandler; J Hutton; A Cooke
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.